Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung CancerValsamo Anagnostou, Victor E. Velculescu, Kellie N. Smith et al.|Cancer Discovery|2016Cited by 909
Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor CellsHsing-Chen Tsai, Cynthia A. Zahnow, Huili Li et al.|Cancer Cell|2012Cited by 652
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung CancerMichael J. Topper, Stephen B. Baylin, Michelle Vaz et al.|Cell|2017Cited by 521
Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancersHuili Li, Nita Ahuja, Katherine B. Chiappinelli et al.|Oncotarget|2014Cited by 443
Alterations of immune response of non-small cell lung cancer with AzacytidineJohn Wrangle, Stephen B. Baylin, Kristen Rodgers et al.|Oncotarget|2013Cited by 391